MedTrace Logo

Oocyte Cryopreservation

NCT01232972 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2013-04-23

No results posted yet for this study

Summary

The purpose of this investigation is to offer the opportunity for young women to cryopreserve (freeze) their oocytes (eggs) for use with IVF at a later point in time.

Conditions

Interventions

PROCEDURE

vitrification of oocytes

eggs will be preserved via vitrification the day they are retrieved from the participant

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Avner Hershlag, MD · Center for Human Reproduction

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01232972 on ClinicalTrials.gov